Form 8-K - Current report:
SEC Accession No. 0001493152-25-009386
Filing Date
2025-03-06
Accepted
2025-03-06 16:10:29
Documents
17
Period of Report
2025-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54839
2 ex99-1.htm EX-99.1 51680
3 ex99-1_001.jpg GRAPHIC 114015
4 ex99-1_002.jpg GRAPHIC 80437
5 ex99-1_003.jpg GRAPHIC 168878
  Complete submission text file 0001493152-25-009386.txt   794585

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE xtnt-20250306.xsd EX-101.SCH 3027
7 XBRL LABEL FILE xtnt-20250306_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE xtnt-20250306_pre.xml EX-101.PRE 24173
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3620
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 25715308
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)